A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron

A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron

Abstract COVID-19 caused, as of September, 1rst, 2022, 599,825,400 confirmed cases, including 6,469,458 deaths. Currently used vaccines reduced severity and mortality but not virus transmission or reinfection by different strains. They are based on the Spike protein of the Wuhan reference virus, whi...

Full description

Bibliographic Details
Main Authors: Iam Palatnik-de-Sousa, Zachary S. Wallace, Stephany Christiny Cavalcante, Maria Paula Fonseca Ribeiro, João Antônio Barbosa Martins Silva, Rafael Ciro Cavalcante, Richard H. Scheuermann, Clarisa Beatriz Palatnik-de-Sousa
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21207-2

Internet

https://doi.org/10.1038/s41598-022-21207-2

Similar Items